{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:52:49Z","timestamp":1783075969458,"version":"3.54.6"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1097\/ftd.0000000000001137","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T19:00:28Z","timestamp":1693508428000},"page":"708-710","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Enantiomer Plasma Concentrations of Tranylcypromine as a Test for Peripheral Monoamine Oxidase Inhibition"],"prefix":"10.1097","volume":"45","author":[{"given":"Sven","family":"Ulrich","sequence":"first","affiliation":[{"name":"Aristo Pharma GmbH, Medical-Scientific Department, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pichit","family":"Buspavanich","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Research Unit Gender in Medicine, Institute of Sexology and Sexual Medicine, Berlin, Germany;"},{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany;"},{"name":"Brandenburg University of Technology, Cottbus-Senftenberg and Brandenburg Medical School, Potsdam, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schlattmann","sequence":"additional","affiliation":[{"name":"Department of Statistics, Informatics and Data Sciences, Jena University Hospital, Jena, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Buchbauer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Campus Charit\u00e9 Mitte, Berlin, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Hindinger","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Behr","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany;"},{"name":"Brandenburg University of Technology, Cottbus-Senftenberg and Brandenburg Medical School, Potsdam, Germany;"},{"name":"Department of Psychiatry and Psychotherapy, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Campus Charit\u00e9 Mitte, Berlin, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Ricken","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Campus Charit\u00e9 Mitte, Berlin, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazda","family":"Adli","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Campus Charit\u00e9 Mitte, Berlin, Germany; and"},{"name":"Department of Psychiatry and Psychotherapy, Fliedner Klinik Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.euroneuro.2017.05.007","article-title":"Tranylcypromine in mind (Part I): Review of pharmacology","volume":"27","author":"Ulrich","year":"2017","journal-title":"Eur Neuropsychopharmacol."},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0378-4347(92)80580-J","article-title":"Enantiospecific high-performance liquid chromatographic assay with fluorescence detection for the monoamine oxidase inhibitor tranylcypromine and its applicability in pharmacokinetic studies","volume":"584","author":"Spahn-Langguth","year":"1992","journal-title":"J Chromatogr B: Biomed Sci Appl."},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000407509","article-title":"Kinetics of MAO inhibitors","volume":"19","author":"Mutschler","year":"1983","journal-title":"Mod Probl Pharmacopsychiat"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2125.1980.tb05852.x","article-title":"Effects of tranylcypromine stereoisomers on monamine oxidation in man","volume":"9","author":"Reynolds","year":"1980","journal-title":"Br J Clin Pharmacol."},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5414\/CP204169","article-title":"Insufficient recovery of monoamine oxidase in a bioequivalence study of the monoamine oxidase inhibitor tranylcypromine: recommendation of the tranylcypromine enantiomer test","volume":"60","author":"Ulrich","year":"2022","journal-title":"Int J Clin Pharmacol Ther."},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00004714-199006000-00004","article-title":"Plasma tranylcypromine: relationship to pharmacokinetic variables and clinical antidepressant actions","volume":"10","author":"Mallinger","year":"1990","journal-title":"J Clin Psychopharmacol."},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4088\/JCP.v58n0704","article-title":"Rapid conversion from one monoamine oxidase inhibitor to another","volume":"58","author":"Szuba","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1078-0432.CCR-20-4054","article-title":"Clinical responsiveness to all-trans retinoic acid is potentiated by LSD1 inhibition and associated with a quiescent transcriptome in myeloid malignancies","volume":"27","author":"Tayari","year":"2021","journal-title":"Clin Cancer Res."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:07:48Z","timestamp":1748970468000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001137","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,24]]}}}